Home > Insider Trading > Filing (0001179110-16-018951)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235010	Momenta Pharmaceuticals Inc	MNTA	Biological Products, (No Disgnostic Substances) (2836)	043561634

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1427944	M. James Roach	C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142	Senior Vp, Development And Chi	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-02-09	17,100	$0.00	107,541	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2016-02-09	34,200	$0.00	34,200	$10.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
34,200	2017-02-09	2026-02-09	No	4	A	Direct

Footnotes

Represents 17,100 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Roach. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on February 9, 2017 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter.
Represents options granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria such options vest with 25% shares of such option one year following the date of grant and 6.25% shares of such option shall vest at the end of each three-month period thereafter.